Gilead Upgraded by Morgan Stanley on Lenacapavir Potential

Seeking Alpha02:11

This McDonald's Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday

Benzinga01:36

Redburn Atlantic Adjusts Price Target on Gilead Sciences to $125 From $123, Keeps Buy Rating

MT Newswires01:31 · Ratings

Today's Analyst Rating | Deutsche Bank Upgrades Boston Scientific to Buy, Morgan Stanley Upgrades Gilead Sciences to Buy

Jan 10, Wall Street analysts have updated their stock ratings today including $Boston Scientific(BSX.US)$ and $Gilead Sciences(GILD.US)$.

Futu NewsJan 10 21:00 · Ratings

Gilead Sciences Analyst Ratings

BenzingaJan 10 19:29 · Ratings

Express News | Gilead Sciences Inc. : Morgan Stanley Raises to Overweight From Equal-Weight

BreakingsJan 10 19:28